Figure 2 The global prevalence of glaucoma among individuals aged 40 to 80 years is estimated at 3.54% (15)
Research published in the context of the SURPASS trial program demonstrated that tirzepatide produced dose-dependent HbA1c reductions of 1.24 to 2.58 percent across the studied dose range, and body weight reductions of 5.4 to 11.7 kilograms in patients with type 2 diabetes
That's our job
M.OrellanaH
Zhang HE, Hamson EJ, Koczorowska MM, Tholen S, Chowdhury S, Bailey CG, et al
J Physiol 577:5919, PMID: 17008380 Lehre KP, Levy LM, Ottersen OP, Storm-Mathisen J, Danbolt NC (1995) Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations